Rashid, Shirya

Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9

Rashid, S., Curtis, D. E., Garuti, R., Anderson, N. N., Bashmakov, Y., Ho, Y. K., Hammer, R. E., Moon, Y.-A., & Horton, J. D. (2005) · Proceedings of the National Academy of Sciences

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 679

Adipocyte hypertrophy, fatty liver, and metabolic risk factors in South Asians: The Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE)

Anand, S. S., Tarnopolsky, M. A., Rashid, S., Schulze, K. M., Desai, D., Mente, A., Rao, S., Yusuf, S., Gerstein, H. C., & Sharma, A. M. (2011) · PLoS ONE

Adipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and Adiposity

Cited by 174

Expression of SREBP-1c Requires SREBP-2-mediated Generation of a Sterol Ligand for LXR in Livers of Mice

Rong, S., Cortés, V. A., Rashid, S., Anderson, N. N., McDonald, J. G., Liang, G., Moon, Y.-A., Hammer, R. E., & Horton, J. D. (2017) · eLife

Cholesterol and Lipid MetabolismCancer, Lipids, and Metabolism

Cited by 134

On the function and homeostasis of PCSK9: Reciprocal interaction with LDLR and additional lipid effects

Tavori, H., Rashid, S., & Fazio, S. (2015) · Atherosclerosis

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 86

Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction

Tavori, H., Melone, M., & Rashid, S. (2014) · Expert Review of Cardiovascular Therapy

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 21